名称 | 开发公司 | 临床周期 | 适应症* |
M6620 | MerckKGaA | I | AST; HNSCC; OC |
II | mCRPC; UC; SCLC; NSCLC; | ||
AZD-6738 | AstraZeneca | I | AST; CLL; NHL; MDS; CMML |
II | BDC; SCLC; NSCLC; PC; TNBC | ||
BAY-1895344 | Bayer | I | AST |
II | AST; lymphomas | ||
M4344 | MerckKGaA | I | AST; OC |
II | BC | ||
RP-3500 | Repare Therapeutics | Ib/II | AST |
I/IIa | AST | ||
ART-0380 | Artios Pharma | I/IIa | AST; MC; OC; PPC; FTC |
ATRN-119 | Atrin Pharmaceuticals | I/IIa | AST |
M1774 | MerckKGaA | I | AST |
ATG-018 | 德琪医药 | I | AST; hematological malignancy |
SC0245 | 智康弘仁 | I | AST |
HRS2398 | 恒瑞医药 | I | AST |
IMP9064 | 英派药业 | I | AST |